Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database.

In addition, when considering severe hypoglycemia requiring medical assistance (hospital admission or the help of a health care professional), the difference in favor of vildagliptin was pronounced, even if it did not reach statistical significance due to lower numbers of patients included in this study: 0.0/1,000 patient-years (95% CI: 0.0; 47.7) with vildagliptin versus 29.7/1,000 patient-years (95% CI 13.6; 56.4) with IS ( P =0.1243).

also in 111,027 other papers